Clinical Research Directory
Browse clinical research sites, groups, and studies.
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Sponsor: University of Washington
Summary
The study is a randomized, double-blind, parallel-group clinical trial to examine the effects of 24 weeks of oral AMX0035 (sodium phenylbutyrate + taurursodiol) versus placebo in 60 adults with Type 1 Diabetes (T1D) (n=30 per arm). Enrollment will be distributed equally between the University of Washington and Amsterdam University Medical Center/Diabetes Center Amsterdam. Participants will be recruited through diabetes research registries, local T1D clinics, and community outreach.
Key Details
Gender
All
Age Range
18 Years - 69 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-09
Completion Date
2029-12
Last Updated
2026-09-15
Healthy Volunteers
No
Conditions
Interventions
AMX0035
AMX0035 sachets
Placebo
Placebo sachets
Locations (2)
University of Washington Medicine Diabetes Institute (UWMDI)
Seattle, Washington, United States
Amsterdam UMC
Amsterdam, Netherlands